Proteomics Market Expected to Reach $98.1 Billion by 2031

Proteomics Market Size was valued at $23,654.34 million in 2021, and is projected to reach $98,051.83 million by 2031, growing at a CAGR of 15.2% from 2022 to 2031. Proteomics studies the interactions, functions, compositions, and structures of proteins and their cellular activities. Proteomics provides a better understanding of the structure and function of the organism than genomics. It has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells. It is estimated that there are almost one million human proteins, many of which contain some modifications such as post-translational modifications (PTMs). However, it is also estimated that the human genome codes for about 26000-31000 proteins for an average of three proteins, one gene can code for several protein products, whereas some genes code only for RNA. Even with improved genome analysis, computation alone is simply not enough to generate an accurate gene number.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Bio-Rad Laboratories Inc, Perkin Elmer Inc, Danaher Corporation, Agilent Technologies Inc., Horiba Ltd., Li-Cor Inc, Waters Corporation, Merck KGaA, Bruker Corporation, Thermo Fisher Scientific Inc.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1677

The protein microarray segment generated the highest Proteomics Market Share in 2021, owing to high usage of this technology to track protein interactions in lesser time as compared to other technologies. Moreover, this method is labor-intensive and cost-effective. With the help of a protein array, comprehensive information about the DNA/RNA binding proteins can be made available. By reagents segment, immunoassays generated the highest revenue in 2021 in the proteomics market, as they are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of application, the drug discovery segment accounted for the majority share in 2021, owing to an increase in awareness about personalized medicines in both emerging and developed markets.

North America held the largest share of nearly 40.0% of the total market in 2021, due to an increase in the popularity and adoption of personalized medicines, increasing investment in the development of structure-based drug design, growing research in the field of omics, and favorable government funding & initiatives to develop novel therapeutics. Moreover, the availability of a large number of key players and the surge in R&D activities in this region are the factors supporting the Proteomics Market Growth.

However, Asia-Pacific is expected to grow at a CAGR of 18.0% from 2022 to 2031, owing to a rise in the prevalence of cancer and chronic diseases and the increase in the interest of researchers to utilize proteomics in disease diagnosis & treatment.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/1677

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.